Kirsten O’Doherty is the ANZ General Manager of biopharmaceutical company, AbbVie where she leads a team of 300+ staff across Australia and New Zealand. She is a member of the AbbVie regional leadership team in Asia, including Japan.
AbbVie is focused on discovering, developing, and delivering medicines in therapeutic areas where the company has proven expertise and where the most impact can be made. These areas include immunology, oncology, virology and neuroscience. For five years in a row, AbbVie has been recognised on the Australian Financial Review’s Most Innovative Companies list and has been named one of Australia’s ‘Best Places to Work’ for several consecutive years.
Originally qualified and working as a hospital pharmacist, Kirsten’s career has subsequently spanned more than 20 years in the Australian pharmaceutical industry, moving from initial clinical research and medical roles to commercial roles, and finally into senior leadership roles. Throughout her career, Kirsten has remained committed to continuing professional development. She is a Graduate of the Australian Institute of Company Directors, and has undertaken residential senior leadership programs at the London Business School, and at IMD in Switzerland.
Kirsten has a breadth and depth of experience including leadership of financial performance, marketing and sales excellence, strategic planning, change management and creating high levels of employee engagement.
Kirsten is on the Board of Medicines Australia, the industry association for the pharmaceutical industry in Australia and is the Chair of the Nominations committee.